FDA
-
-
-
-
-
-
-
Merck to Acquire Imago BioSciences, Inc.
-
-
-
-
-
-
-
Imago BioSciences (IMGO) Reports Positive Data from Ongoing Phase 2 Study of Bomedemstat
-
-
-
-
-
-
-
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer
-
-
-
-
-
-
-
Imago BioSciences (IMGO) Reports Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis
-
-
-
-
-
-
-
Imago BioSciences to Present at Stifel 2021 Virtual Healthcare Conference
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

